PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

BMY-2024-Q2-Results-Investor-Presentation - Bristol Myers Squibb | Presentation Nation

HomepageBristol Myers SquibbBMY-2024-Q2-Results-Investor-Presentation

BMY-2024-Q2-Results-Investor-Presentation

Bristol Myers Squibb

Browse presentations, reports, and documents from Bristol Myers Squibb.

Tags

2024

Filter options

All (143)●
whitepaper (2)○
investor_presentation (1)○
presentation (63)○
report (20)○
annual_report (2)○
conference (3)○
infographic (15)○
brochure (37)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

BMY-2024-Q2-Results-Investor-Presentation by Bristol Myers Squibb.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Bristol Myers Squibb

201217_Updated_COVID-9%20Infographic%20NOUK2001369-01

infographic

2019-BMY-CELG-JPM-Investor-Presentation

presentation

Similar presentations from other companies

230122_Cellcom%20Investor%20Presentation.

presentation

Cellcom Israel

MarketAxess Holdings_January_2019_833_37833

presentation

MarketAxess Holdings

2022-bms-annual-report

report

2022-Q2-Quarterly-Earnings-Infographic

infographic

2022-Q3-Quarterly-Earnings-Infographic

infographic

2022-Q4-Quarterly-Earnings-Infographic

infographic

ENI SpA_July_2024_421_102421

presentation

ENI SpA

Fireweed Zinc_May_2018_437_28437

presentation

Fireweed Zinc

SecureWorks_December_2022_702_89702

presentation

SecureWorks

Finch Therapeutics Group_September_2021_601_74601

presentation

Finch Therapeutics Group